2016. Determination of receptor and HER2 status of breast cancer using tissue matrix technology. Validation of the method. Voprosy onkologii. 62, 2 (Dec. 2016), 314–319. DOI:https://doi.org/10.37469/0507-3758-2016-62-2-314-319.